Insider Selling: Privia Health Group, Inc. (NASDAQ:PRVA) CFO Sells 3,445 Shares of Stock

Privia Health Group, Inc. (NASDAQ:PRVAGet Free Report) CFO David Mountcastle sold 3,445 shares of Privia Health Group stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total transaction of $80,371.85. Following the completion of the transaction, the chief financial officer now directly owns 176,231 shares of the company’s stock, valued at approximately $4,111,469.23. This trade represents a 1.92 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

David Mountcastle also recently made the following trade(s):

  • On Wednesday, April 2nd, David Mountcastle sold 5,630 shares of Privia Health Group stock. The shares were sold at an average price of $22.38, for a total value of $125,999.40.

Privia Health Group Trading Up 1.8 %

PRVA opened at $23.32 on Friday. Privia Health Group, Inc. has a 1-year low of $15.92 and a 1-year high of $26.04. The company has a market cap of $2.83 billion, a P/E ratio of 233.22, a price-to-earnings-growth ratio of 3.47 and a beta of 0.88. The company has a fifty day moving average price of $23.50 and a two-hundred day moving average price of $22.10.

Institutional Investors Weigh In On Privia Health Group

A number of hedge funds have recently added to or reduced their stakes in PRVA. Rhumbline Advisers increased its holdings in Privia Health Group by 1.3% during the 4th quarter. Rhumbline Advisers now owns 287,200 shares of the company’s stock worth $5,615,000 after purchasing an additional 3,658 shares in the last quarter. Nordea Investment Management AB raised its stake in shares of Privia Health Group by 33.1% in the fourth quarter. Nordea Investment Management AB now owns 349,773 shares of the company’s stock valued at $6,953,000 after buying an additional 86,910 shares during the period. Franklin Resources Inc. lifted its holdings in Privia Health Group by 2.2% during the third quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock valued at $23,092,000 after purchasing an additional 28,480 shares during the last quarter. Barclays PLC lifted its stake in shares of Privia Health Group by 240.3% during the 3rd quarter. Barclays PLC now owns 224,018 shares of the company’s stock valued at $4,079,000 after buying an additional 158,188 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its holdings in shares of Privia Health Group by 8.4% in the third quarter. JPMorgan Chase & Co. now owns 188,384 shares of the company’s stock worth $3,430,000 after acquiring an additional 14,641 shares during the period. Institutional investors and hedge funds own 94.48% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently commented on the stock. Piper Sandler upped their price target on shares of Privia Health Group from $25.00 to $40.00 and gave the company an “overweight” rating in a research note on Friday, February 28th. Truist Financial upped their price objective on shares of Privia Health Group from $27.00 to $28.00 and gave the stock a “buy” rating in a research report on Thursday, April 10th. Canaccord Genuity Group lifted their price target on Privia Health Group from $29.00 to $30.00 and gave the company a “buy” rating in a research note on Friday, February 28th. Robert W. Baird raised their price objective on Privia Health Group from $24.00 to $26.00 and gave the company an “outperform” rating in a report on Tuesday, April 15th. Finally, Barclays raised their price target on shares of Privia Health Group from $21.00 to $23.00 and gave the company an “equal weight” rating in a research note on Thursday, April 10th. One equities research analyst has rated the stock with a hold rating, eleven have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $27.38.

View Our Latest Research Report on Privia Health Group

About Privia Health Group

(Get Free Report)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Read More

Insider Buying and Selling by Quarter for Privia Health Group (NASDAQ:PRVA)

Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.